Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Lexeo Therapeutics (LXEO) Return on Equity (2023 - 2026)

Lexeo Therapeutics' Return on Equity history spans 1 years, with the latest figure at 0.03% for Q4 2023.

  • On a quarterly basis, Return on Equity changed N/A to 0.03% in Q4 2023 year-over-year; TTM through Dec 2023 was 0.03%, a N/A change, with the full-year FY2023 number at 2.29%, changed N/A from a year prior.
  • Return on Equity hit 0.03% in Q4 2023 for Lexeo Therapeutics, up from 0.0% in the prior quarter.
  • Over the last five years, Return on Equity for LXEO hit a ceiling of 0.03% in Q4 2023 and a floor of 0.0% in Q3 2023.